Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies.

Bimzelx (bimekizumab-bkzx) - UCB

http://www.ncbi.nlm.nih.gov/pubmed/42152504

Ana-Maria Orbai; Barbara Ink; Dafna D Gladman; Fabian Proft; Jérémy Lambert; Laura C Coates; Laure Gossec; M Elaine Husni; Maarten de Wit; Patrick Healy; Philip J Mease; Rajan Bajracharya; William Tillett

May 20, 2026